# Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

> **NCT02841709** · PHASE2 · COMPLETED · sponsor: **Idorsia Pharmaceuticals Ltd.** · enrollment: 58 (actual)

## Conditions studied

- Insomnia Disorder

## Interventions

- **DRUG:** ACT-541468
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02841709
- **Lead sponsor:** Idorsia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-28
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-06-29
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02841709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02841709, "Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02841709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*